OCGN
#2984
Ocugen, Inc. - Common Stock
1.3 2 USD
-0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-3.65%
Changement Mensuel
+6.45%
Evolution sur 6 mois
-20.48%
Changement Annuel
+30.69%
Clôture Précédente
1.3 7
Open
1.3 2
Low
1.3 2
High
1.3 2
Volume
76
Financials
- Market Capitalization 447.63 M
- Employee 116
- Founded 2013
- CEO Shankar Musunuri
- Website www.ocugen.com
- Headquarter Delaware, United States
- FIGI BBG00194VJB1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.88
ratio cours/chiffre d'affaires
106.63
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2981 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 13.17 USD | -4.84% | -0.30% | +4.28% | -10.41% | 449.98 M USD | ||
| 2983 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.98 USD | -3.99% | -4.12% | -13.93% | -21.40% | 449.10 M USD | ||
| 2988 |  RZLT Rezolute, Inc. - Common Stock | 4.62 USD | -7.23% | -8.15% | +1.76% | -35.11% | 444.87 M USD | ||
| 3011 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.47 USD | -13.72% | -17.50% | +17.63% | +355.83% | 436.53 M USD |